- Categories
-
Synvisc 3x2ml
Synvisc is a preparation used to treat osteoarthritis and ensure proper functioning of the joints.
Reviews | |
Shipping within | 24 hours |
Shipping price | The Lack Of |
Telephone order: 697197052
Synvisc is an over-the-counter product in the form of a sterile, colorless, clear, viscous and flexible solution containing hylan polymers A and B produced on the basis of a highly purified extract of bird origin. Hylans are derivatives of hyaluronan (the sodium salt of hyaluronic acid) that contain the repeating disaccharide units of N-acetyl-glucosamine and sodium glucuronate.
Indications:
- In the treatment of symptomatic degenerative disease located within the knee, ankle, shoulder and hip joints,
- In periodic replacement and supplementation of synovial fluid, in patients at different stages of degenerative changes in the joints.
1 ml of G-F 20 hylan contains:
- Hylan 8.0 mg,
- Sodium chloride 8.5 mg,
- Disodium hydrogen phosphate 0.16 mg,
- Sodium dihydrogen phosphate monohydrate 0.04 mg,
- Water for injections q.s.
Use:
Analgesic therapy of the knee joint: administer 3 intra-articular injections of 2 ml into the knee joint, one week apart; remove the exudate beforehand.
Ankle joint, shoulder joint, hip joint: a single injection of 2 ml, if there is no improvement, a second injection is recommended between 1 and 3 months after the first dose.
Administer the preparation only into the synovial space. Avoid periarticular injection, injection into the synovium or into the joint capsule. If necessary, perform fluoroscopy in the hip and shoulder joints. Ionic or non-ionic contrasts can be used - do not use more than 1 ml of contrast agent per 2 ml of the preparation.
Package:
16mg / 2ml - 3 pre-filled syringes x 2 ml
The product may only be used by professionals.
Note: The promotional code received for subscribing to the newsletter is not valid for the Synvisc 3x2ml product.
By purchasing the product, you declare that you are a doctor or cosmetologist
trained in aesthetic medicine.
Manufacturer details
Genzyme Corporation
1125 Pleasantview Ter
NJ 07657 Ridgefield
United States
genzyme.globalcontact@genzyme.com
Responsible person
Genzyme Europe B.V.
Paasheuvelweg 25
1105 BP Amsterdam
Netherlands
Multichannel.Marketing@sanofi.com
- Manufacturers